| Authors: |
Dinmohamed AG; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Kater AP; Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and., Raymakers RAP; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. |
